Early Feeding Following Percutaneous Gastrostomy Tube Placement
NCT ID: NCT03319576
Last Updated: 2019-10-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2017-10-30
2019-10-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilot Study of Time Restricted Feeding as a Weight Loss Intervention
NCT03571048
The Effects of Energy Imbalance on Food Intake Behaviors
NCT03112161
Piloting a Novel Intuitive Eating Intervention for College Women With Disordered Eating
NCT03612661
The Effect of Time-restricted Feeding on Physiological Function in Middle-aged and Older Adults
NCT02970188
Psychological Mechanisms Linking Food Insecurity and Obesity
NCT03441594
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early feeding
Patients randomized to early feeding will be fed 4 hours following gastrostomy tube placement
Feeding at 4 hours
Patients will be fed 4 hours after their gastrostomy tube placement procedure.
Standard feeding
Patients randomized to standard feeding will be fed 24 hours following gastrostomy tube placement
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Feeding at 4 hours
Patients will be fed 4 hours after their gastrostomy tube placement procedure.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Outpatients receiving a gastrostomy tube at University of Colorado that do not require post-pyloric feeding
* Patients that have no contraindication for intragastric feeding immediately following tube placement
* INR (international normalized ratio) \<1.5
* Platelet count \> 50,000/µL
* WBC (white blood cell count) 4.0-11.1 x 109/L
Exclusion Criteria
* Patients admitted to the hospital at the time of screening (i.e., inpatients)
* Women who are pregnant (confirmed by urine pregnancy screen)
* Patients requiring post-pyloric feeding
* Patients receiving venting gastrostomy tubes
* Patients receiving primary Gastro-Jejunal (GJ) Tube tube placement
* Patients with an interposed bowel on CT after stomach insufflation
* INR \> 1.5
* Platelet count \< 50,000/µL
* WBC \> 11.1 x 109/L
* Known active infection
* Need for post-gastric feeding
* History of gastric bypass surgery or Roux-En-Y
* Mechanical obstruction of the GI tract
* Active peritonitis
* Known hemodynamic instability as demonstrated by tachycardia, hypotension, labile blood pressure or altered mental status.
* Bowel ischemia
* Ascites
* Recent Gastro-Intestinal (GI) bleeding (within 2 weeks)
* Respiratory compromise as demonstrated by hypercarbia (CO2\>45mmHg) or hypoxia (O2\<90%)
* Unable to provide informed consent
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Colorado, Denver
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Premal Trivedi, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Colorado, Denver
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Colorado
Aurora, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16-1074
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.